Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acid

Abstract Background 5-Aminolevulinic acid (5-ALA) is a promising biostimulant, feed nutrient, and photodynamic drug with wide applications in modern agriculture and therapy. Although microbial production of 5-ALA has been improved realized by using metabolic engineering strategies during the past fe...

Full description

Bibliographic Details
Main Authors: Wei Pu, Jiuzhou Chen, Yingyu Zhou, Huamin Qiu, Tuo Shi, Wenjuan Zhou, Xuan Guo, Ningyun Cai, Zijian Tan, Jiao Liu, Jinhui Feng, Yu Wang, Ping Zheng, Jibin Sun
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Biotechnology for Biofuels and Bioproducts
Subjects:
Online Access:https://doi.org/10.1186/s13068-023-02280-9
_version_ 1797789855486312448
author Wei Pu
Jiuzhou Chen
Yingyu Zhou
Huamin Qiu
Tuo Shi
Wenjuan Zhou
Xuan Guo
Ningyun Cai
Zijian Tan
Jiao Liu
Jinhui Feng
Yu Wang
Ping Zheng
Jibin Sun
author_facet Wei Pu
Jiuzhou Chen
Yingyu Zhou
Huamin Qiu
Tuo Shi
Wenjuan Zhou
Xuan Guo
Ningyun Cai
Zijian Tan
Jiao Liu
Jinhui Feng
Yu Wang
Ping Zheng
Jibin Sun
author_sort Wei Pu
collection DOAJ
description Abstract Background 5-Aminolevulinic acid (5-ALA) is a promising biostimulant, feed nutrient, and photodynamic drug with wide applications in modern agriculture and therapy. Although microbial production of 5-ALA has been improved realized by using metabolic engineering strategies during the past few years, there is still a gap between the present production level and the requirement of industrialization. Results In this study, pathway, protein, and cellular engineering strategies were systematically employed to construct an industrially competitive 5-ALA producing Escherichia coli. Pathways involved in precursor supply and product degradation were regulated by gene overexpression and synthetic sRNA-based repression to channel metabolic flux to 5-ALA biosynthesis. 5-ALA synthase was rationally engineered to release the inhibition of heme and improve the catalytic activity. 5-ALA transport and antioxidant defense systems were targeted to enhance cellular tolerance to intra- and extra-cellular 5-ALA. The final engineered strain produced 30.7 g/L of 5-ALA in bioreactors with a productivity of 1.02 g/L/h and a yield of 0.532 mol/mol glucose, represent a new record of 5-ALA bioproduction. Conclusions An industrially competitive 5-ALA producing E. coli strain was constructed with the metabolic engineering strategies at multiple layers (protein, pathway, and cellular engineering), and the strategies here can be useful for developing industrial-strength strains for biomanufacturing.
first_indexed 2024-03-13T01:56:28Z
format Article
id doaj.art-88fa2651067c49288dc02b462e12214f
institution Directory Open Access Journal
issn 2731-3654
language English
last_indexed 2024-03-13T01:56:28Z
publishDate 2023-02-01
publisher BMC
record_format Article
series Biotechnology for Biofuels and Bioproducts
spelling doaj.art-88fa2651067c49288dc02b462e12214f2023-07-02T11:10:13ZengBMCBiotechnology for Biofuels and Bioproducts2731-36542023-02-0116111610.1186/s13068-023-02280-9Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acidWei Pu0Jiuzhou Chen1Yingyu Zhou2Huamin Qiu3Tuo Shi4Wenjuan Zhou5Xuan Guo6Ningyun Cai7Zijian Tan8Jiao Liu9Jinhui Feng10Yu Wang11Ping Zheng12Jibin Sun13Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyKey Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences, Tianjin Institute of Industrial BiotechnologyAbstract Background 5-Aminolevulinic acid (5-ALA) is a promising biostimulant, feed nutrient, and photodynamic drug with wide applications in modern agriculture and therapy. Although microbial production of 5-ALA has been improved realized by using metabolic engineering strategies during the past few years, there is still a gap between the present production level and the requirement of industrialization. Results In this study, pathway, protein, and cellular engineering strategies were systematically employed to construct an industrially competitive 5-ALA producing Escherichia coli. Pathways involved in precursor supply and product degradation were regulated by gene overexpression and synthetic sRNA-based repression to channel metabolic flux to 5-ALA biosynthesis. 5-ALA synthase was rationally engineered to release the inhibition of heme and improve the catalytic activity. 5-ALA transport and antioxidant defense systems were targeted to enhance cellular tolerance to intra- and extra-cellular 5-ALA. The final engineered strain produced 30.7 g/L of 5-ALA in bioreactors with a productivity of 1.02 g/L/h and a yield of 0.532 mol/mol glucose, represent a new record of 5-ALA bioproduction. Conclusions An industrially competitive 5-ALA producing E. coli strain was constructed with the metabolic engineering strategies at multiple layers (protein, pathway, and cellular engineering), and the strategies here can be useful for developing industrial-strength strains for biomanufacturing.https://doi.org/10.1186/s13068-023-02280-95‑Aminolevulinic acidSystems metabolic engineeringEscherichia coliSynthetic sRNAAntioxidant defense system
spellingShingle Wei Pu
Jiuzhou Chen
Yingyu Zhou
Huamin Qiu
Tuo Shi
Wenjuan Zhou
Xuan Guo
Ningyun Cai
Zijian Tan
Jiao Liu
Jinhui Feng
Yu Wang
Ping Zheng
Jibin Sun
Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acid
Biotechnology for Biofuels and Bioproducts
5‑Aminolevulinic acid
Systems metabolic engineering
Escherichia coli
Synthetic sRNA
Antioxidant defense system
title Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acid
title_full Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acid
title_fullStr Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acid
title_full_unstemmed Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acid
title_short Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acid
title_sort systems metabolic engineering of escherichia coli for hyper production of 5 aminolevulinic acid
topic 5‑Aminolevulinic acid
Systems metabolic engineering
Escherichia coli
Synthetic sRNA
Antioxidant defense system
url https://doi.org/10.1186/s13068-023-02280-9
work_keys_str_mv AT weipu systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT jiuzhouchen systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT yingyuzhou systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT huaminqiu systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT tuoshi systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT wenjuanzhou systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT xuanguo systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT ningyuncai systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT zijiantan systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT jiaoliu systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT jinhuifeng systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT yuwang systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT pingzheng systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid
AT jibinsun systemsmetabolicengineeringofescherichiacoliforhyperproductionof5aminolevulinicacid